Drug details:
Molecular formula: C₁₆H₁₄BrN₃OS

Standard name: N-(4-bromophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)sulfanyl]acetamide

Synonym:

N-(4-bromophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)sulfanyl]acetamide

Curated SMILES: CC1=CC=C2NC(SCC(=O)NC3=CC=C(Br)C=C3)=NC2=C1

Evidence for compound's anti-virulence activity:

Pseudomonas
Related VFcategory: Biofilm
Target: MvfR
Drug effect: Inhibits MvfR-regulated virulence functions.
Max phase: Preclinical (in vitro)
Publication:
Starkey M, et al., 2014. Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog 10(8):e1004321.